The New York Times, November 19, 2025 (with Pam Belluck)
Gene-editing therapies offer great hope for treating rare diseases, but they face big hurdles: the tremendous time and resources involved in devising a treatment that might only apply to a small number of patients.
A study published on Wednesday outlines a new approach that could make the process more efficient and less costly. Writing in the journal Nature, researchers presented a path toward a gene-editing strategy that could eventually be standardized for many different rare diseases, instead of personalized edits for each one.
Continue reading “New Gene-Editing Strategy Could Help Development of Treatments for Rare Diseases”